Cargando…
Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer
Colorectal cancer is the third most frequently diagnosed cancer malignancy and the second leading cause of cancer-related deaths worldwide. Therefore, it is of utmost importance to provide new therapeutic options that can improve survival. Sphingomyelin nanosystems (SNs) are a promising type of nano...
Autores principales: | Bouzo, Belén L., Lores, Saínza, Jatal, Raneem, Alijas, Sandra, Alonso, María José, Conejos-Sánchez, Inmaculada, de la Fuente, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390746/ https://www.ncbi.nlm.nih.gov/pubmed/34446776 http://dx.doi.org/10.1038/s41598-021-96578-z |
Ejemplares similares
-
Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics
por: Nagachinta, Surasa, et al.
Publicado: (2020) -
Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model
por: Saraiva, Sofia M., et al.
Publicado: (2021) -
Modulation of Colorectal Tumor Behavior via lncRNA TP53TG1-Lipidic Nanosystem
por: Masoumi, Farimah, et al.
Publicado: (2021) -
Uroguanylin Improves Leptin Responsiveness in Diet-Induced Obese Mice
por: Folgueira, Cintia, et al.
Publicado: (2019) -
Role of uroguanylin's signalling pathway in the development of ischaemic stroke
por: Ratko, Martina, et al.
Publicado: (2022)